Bristol-Myers to test Opdivo with Nektar drug for several cancers

(Reuters) – Bristol-Myers Squibb Co said on Tuesday it would evaluate the use of its blockbuster cancer immunotherapy Opdivo in combination with an experimental drug from Nektar Therapeutics to treat multiple cancers.

Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *